Seth V. Hetherington

Seth V. Hetherington

Director/Miembro de la Junta en Apie Therapeutics, Inc. .

71 años
Health Technology
Consumer Services
Health Services

Perfil

Seth V.
Hetherington
is currently a Director at Apie Therapeutics, Inc. He previously held positions as Chief Medical Officer & VP-Clinical Development at Inhibitex LLC, SVP-Clinical & Regulatory Affairs at Neusentis, Inc., Chief Medical Officer at Genocea Biosciences, Inc., and Senior VP-Clinical & Regulatory Affairs at Icagen, Inc. He also worked as Head-Clinical Program at GlaxoSmithKline, Inc. and Glaxo Wellcome, Inc. Additionally, he worked as a Principal at The University of North Carolina at Asheville.
Hetherington received his undergraduate degree from Yale University and his doctorate from The University of North Carolina at Asheville.

Cargos activos de Seth V. Hetherington

EmpresasCargoInicio
Director/Miembro de la Junta -
Todos los cargos activos de Seth V. Hetherington

Antiguos cargos conocidos de Seth V. Hetherington.

EmpresasCargoFin
GENOCEA BIOSCIENCES, INC. Director Técnico/Científico/I+D 30/01/2018
Director Técnico/Científico/I+D 31/12/2010
Director Técnico/Científico/I+D 01/12/2010
Director Técnico/Científico/I+D 01/06/2006
Corporate Officer/Principal 01/06/2002
Ver el detalle de la experiencia de Seth V. Hetherington.

Formación de Seth V. Hetherington.

Yale University Undergraduate Degree
The University of North Carolina at Asheville Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Seth V. Hetherington.

Relaciones

72

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
GENOCEA BIOSCIENCES, INC.

Health Technology

Empresas privadas6

Health Technology

Health Technology

Health Technology

Health Technology

Glaxo Wellcome, Inc.

Health Technology

Health Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Seth V. Hetherington